← FDA Drug Approvals (Drugs@FDA)
KAZANO
NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2013-01-25
Drug application
- FDA Application #
NDA203414- Application type
- New Drug Application
- Brand name
- KAZANO
- Generic name
- ALOGLIPTIN AND METFORMIN HYDROCHLORIDE
- Active ingredients
- ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TAKEDA PHARMS USA
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- First approval
- 2013-01-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown